Legal Opinion
Eurand, Inc. v. Mylan Pharmaceuticals, Inc.
District Court, D. Delaware
Decided April 13, 2010No. 08-889-SLRPublishedCited by 2 opinions
1Opinion of the Court
MEMORANDUM ORDER
MARY PAT THYNGE, United States Magistrate Judge.
Plaintiffs and defendants, Mylan Pharmaceuticals, Inc. and Mylan Inc. (“Mylan”), are locked in a discovery dispute that centers on the relevance of recent discovery requests by Mylan. The dispute relates to the '793 patent, which is directed to an extended-release formulation of cyclobenzaprine, and Mylan’s demand for production of documents concerning drugs other than cyclobenzaprine, which is the subject of plaintiffs’ NDA, Mylan’s ANDA and the patent-in-suit. This memorandum order addresses the issues raised in that discovery…
2Cases cited12 opinions
- Star Scientific, Inc. v. R.J. Reynolds Tobacco Co.Court of Appeals for the Federal Circuit · 2008
- Fmc Corporation v. The Manitowoc Company, Inc.Court of Appeals for the Federal Circuit · 1987
- Elk Corporation Of Dallas v. Gaf Building Materials CorporationCourt of Appeals for the Federal Circuit · 1999
- M. Eagles Tool Warehouse, Inc. v. Fisher Tooling Co.Court of Appeals for the Federal Circuit · 2006
- United States v. O'KeefeDistrict Court, District of Columbia · 2008
7 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- First Niagara Risk Management, Inc. v. FolinoDistrict Court, E.D. Pennsylvania · 2016
- Koninklijke Philips N.V. v. Wangs Alliance CorporationDistrict Court, D. Massachusetts · 2018